ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

3 links0 made here, not in the record3 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07429474Safety and Immunogenicityof PRO-169 in Patients WithDiabetic Macular EdemaLaboratorios Sophia S.A de C.VPhase 1 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSImmunogenicityNo longer in the registry's filing›Nov 14 · Our condition-kind rule · Not readNot readAnti-drug Antibodies (ADAs)No longer in the registry's filing›Nov 14 · Our condition-kind rule · Not readNot readDRUGSINT028694Entry “PRO-169”, read by our name rule›As of now · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Immunogenicity

From the registry record1 judgment on this link
Kind of condition link, from the registry to what was judged
RegistryImmunogenicity, once filedthe registry files the study under it
→judged→
On the pageNo longer linkedthe registry no longer files it here

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14ImmunogenicityOur condition-kind ruleNot readCurrent
Nov 14Anti-drug Antibodies (ADAs)Our condition-kind ruleNot readCurrent
As of nowINT028694Our role ruleTestedCurrent